Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Boston Scientific Dl 01 | TG:BSX | Tradegate | Ordinary Share |
| Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
|---|---|---|---|---|---|---|---|---|---|---|
| -1.00 | -1.15% | 86.00 | 85.00 | 86.50 | 87.50 | 85.50 | 87.50 | 2,768 | 22:50:15 |
From Nov 2019 to Nov 2024
A federal appeals court on Wednesday revived an earlier patent infringement ruling about pacemakers against St. Jude Medical Inc. (STJ), possibly leaving the medical devices company on the hook for significant damages.
The U.S. Federal Circuit Court of Appeals, which handles patent appeals, sent the case back to the district court so a judge can award damages to Guidant Corp. and Cardiac Pacemakers Inc., which filed the suit against St. Jude in 1996. Guidant is now a unit of Boston Scientific Corp. (BSX).
Cardiac alleged in its original lawsuit that St. Jude infringed on its patent for a pacemaker, an electronic device implanted in someone's chest that gives pulses or shocks to the heart to help it beat. A jury in 2001 awarded Cardiac $140 million in royalties for patent infringement but another court overturned the ruling.
-By Jared A. Favole, Dow Jones Newswires; 202-862-9207; jared.favole@dowjones.com
1 Year Boston Scientific Dl 01 Chart |
1 Month Boston Scientific Dl 01 Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
